Epidemiological trends and age-period-cohort analysis of alcoholic liver cancer from 1990 to 2021

1990年至2021年酒精性肝癌的流行病学趋势和年龄-时期-队列分析

阅读:1

Abstract

BACKGROUND: The disease burden of alcoholic liver cancer (ALC) has been changing due to socioeconomic development. An up-to-date evaluation of this change can increase public awareness and facilitate health policy development. METHODS: The data were extracted from the Global Burden of Diseases Study (GBD) 2021. Epidemiological changes of morbidity and mortality in different regions, as well as the differences in gender and age were analyzed. Temporal trends were determined using Joinpoint regression analysis and age-period-cohort analysis was employed to evaluate the effects of age, period, and cohort. RESULTS: Globally, there were 99,543.67 new cases (95% UI 80957.40-120401.87) and 92,227.78 deaths (95% UI 75053.11-112,160.27) in 2021, increased by 158.92% and 141.61%, respectively, compared to 1990. Decomposition analysis revealed that population growth was the primary driver of the increased morbidity (41.13%) and mortality (54.87%). The global estimated annual percentage change (EAPC) of morbidity and mortality exhibited an ascending trend, while differences existed across different regions. The morbidity and mortality rates were higher in males than in females across all age groups. Joinpoint regression analysis showed an increased morbidity and mortality rate. The age effect indicated that the highest risk was observed at 75-79 years for morbidity and 80-84 years for mortality. The period effect showed an increasing risk, while improving cohort risks for mortality were identified. CONCLUSION: Alcoholic liver cancer has posed an increasing health burden since 1990, particularly affecting male and the elderly population. Effective prevention policies on specific age groups should be formulated to improve this situation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。